The Good Doctor
Rejoyn Wants to Treat Your Depression Digitally, Experts Aren't Sure - CNET
The app-based treatment for major depression disorder developed by Otsuka Pharmaceutical and Click Therapeutics has received FDA clearance. Here's what to know before it's available this summer.
Rejoyn, the first digital prescription app for major depressive disorder, was just cleared by the US Food and Drug Administration. Approval is based on the data from a 13-week trial of 389 participan… [+5350 chars]
Related
Share this page
Guest Posts by Easy Branches
